Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities

YB-1: oncoprotein, prognostic marker and therapeutic target?

(2013) Annette Lasham et al.   BIOCHEMICAL JOURNAL

Y-Box Binding Protein-1 Mediates Profibrotic Effects of Calcineurin Inhibitors in the Kidney

(2011) L. Hanssen et al.   JOURNAL OF IMMUNOLOGY

Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis

(2011) J. Bontscho et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

(2011) P. V. Hornbeck et al.   NUCLEIC ACIDS RESEARCH

Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody

(2011) Adele G. Woolley et al.   PLoS One

Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells

(2010) Karsten Jürchott et al.   PLoS Genetics

Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen

(2009) Björn C Frye et al.   EMBO REPORTS

YB-1 Acts as a Ligand for Notch-3 Receptors and Modulates Receptor Activation

(2009) Thomas Rauen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing

(2009) S B Cohen et al.   ONCOGENE

Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1

(2008) U.t.e. Raffetseder et al.   KIDNEY INTERNATIONAL

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Y-box protein-1 controls transforming growth factor-β1 translation in proximal tubular cells

(2007) D.J. Fraser et al.   KIDNEY INTERNATIONAL